Related Experiment Video
Updated: Feb 23, 2026

06:33
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
1.9K
Leukemic Cells "Gas Up" Leaky Bone Marrow Blood Vessels
1Division of Regenerative Medicine, Ansary Stem Cell Institute, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.
Cancer Cell
|September 13, 2017
Summary
Leukemia triggers marrow vessel leakiness by increasing reactive oxygen and nitric oxide. This disruption exhausts healthy cells and may cause leukemia relapse after treatment.
Area of Science:
- Hematology
- Oncology
- Vascular Biology
Background:
- Leukemia is a cancer of the blood and bone marrow.
- Tumor microenvironments play a critical role in cancer progression and treatment resistance.
- Vascular integrity is crucial for maintaining tissue homeostasis and function.
Purpose of the Study:
- To investigate the mechanisms by which leukemia disrupts the bone marrow vasculature.
- To understand the role of reactive oxygen species and nitric oxide in leukemia-induced vascular leakiness.
- To explore the implications of vascular disruption for leukemia relapse and non-malignant cell populations.
Main Methods:
- The study utilized a mouse model of leukemia.
- Assessed reactive oxygen species and nitric oxide production in the bone marrow.
- Analyzed vascular permeability and integrity using imaging techniques.
- Evaluated the impact on hematopoietic stem and progenitor cells.
Main Results:
- Leukemia cells aberrantly induce reactive oxygen species and nitric oxide production.
- These molecules trigger significant marrow vessel leakiness.
- Leukemia-associated vascular disruption leads to exhaustion of non-malignant stem and progenitor cells.
- Disrupted vasculature may contribute to treatment resistance and disease relapse.
Conclusions:
- Leukemia actively remodels the bone marrow vasculature to its advantage.
- Targeting vascular integrity could be a novel therapeutic strategy for leukemia.
- Understanding these mechanisms is crucial for preventing leukemia relapse.
Related Concept Videos
Disorders of Leukocytes
2.1K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.1K
Capillaries and Their Types
8.2K
Capillaries, a crucial constituent of the circulatory system, are diminutive vessels with a diameter between 5–10 micrometers, accommodating perfusion to the tissues through the phenomenon known as microcirculation. Through their permeable walls, consisting of an endothelial layer ensconced by a basement membrane and sporadically dispersed smooth muscle fibers, the exchange of substances between the blood and the interstitial fluid becomes plausible. Variance in wall composition exists,...
8.2K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Structure and Function of Leukocytes
4.6K
An adult in good health typically has between 4,500 and 11,000 leukocytes, or white blood cells, per microliter of blood, which constitutes about 1% of the total blood volume. Unlike red blood cells, white blood cells contain a nucleus and other cellular organelles but do not have hemoglobin. Most white blood cells reside in connective tissues, particularly in lymphatic organs such as the lymph nodes, with only a small fraction present in circulating blood.
White blood cells protect the body...
White blood cells protect the body...
4.6K
Differentiation of Common Myeloid Progenitor Cells
4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K

